Medicine & Life Sciences
Prostaglandin H2 Receptors Thromboxane A2
100%
7-(3-(3-hydroxy-4-(4'-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)heptan-2-yl)-5-heptenoic acid
78%
IS 145
56%
Myeloid Cells
46%
Thromboxane A2
43%
Cyclization
37%
Steroids
33%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
31%
Drug Resistance
29%
protein kinase D2
29%
S 145
28%
Oxidoreductases
27%
CCAAT-Enhancer-Binding Protein-delta
26%
Androstenes
25%
Blood Platelets
25%
Acids
25%
Hydroxyzine
23%
androstane
23%
Ribosomal Protein S6
22%
Lactams
21%
Iodine-125
21%
Cell Death
20%
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
20%
Alkylation
19%
Leukemia, Erythroblastic, Acute
19%
Superoxide Dismutase-1
19%
Myeloid Leukemia
18%
Poly(ADP-ribose) Polymerases
17%
Amides
17%
Plasminogen
17%
phorbol-12-myristate
17%
Epoprostenol
17%
Phorbol Esters
16%
Calcium Channels
16%
Cyclic AMP
16%
Site-Directed Mutagenesis
16%
Insecta
15%
Nimodipine
15%
Risk Reduction Behavior
15%
Esters
15%
Acetates
14%
cycloartenol
14%
Informed Consent
14%
Serine
14%
Workplace
14%
Membranes
14%
Chemical Compounds
Thromboxane A2
87%
Thromboxane Receptor Blocking Agent
53%
1,2,4-oxadiazole
43%
Steroid
41%
Thromboxane A2 Receptor Blocking Agent
34%
Antagonist
32%
Heptenoic Acid
28%
Epimerization
26%
Imidazolidin-2-One
25%
Phorbol 13-Acetate 12-Myristate
22%
Amino Acid Amide
22%
Antithrombocytic Agent
22%
Isoflavonoid
22%
Phorbol Ester
21%
2,2-dimethylsuccinic Acid
21%
Primary Amide
20%
Isoflavone
20%
Heptane
19%
Serine Residue
19%
Cyclization Reaction
18%
Reaction Yield
18%
Amide
17%
Radioligand
16%
Lactam
16%
Agonist
16%
Propionic Acid
16%
Quantitative Yield
16%
Aniline
14%
24-Methylenecycloartanol
14%
One Pot Reaction
13%
Alkylation
12%
Cycloartenol
12%
Enantiomer
11%
Toluene
11%
Lanosterol
10%
Thromboxane
10%
Benzamidine
10%
Curtius Rearrangement
10%
Chemical Transformation
9%
Ester
9%
Prostaglandin
8%
BMY 45778
8%
Estrogen
8%
Sodium Iodide
7%
Beraprost
7%
Sulprostone
7%
Reduction
6%
Methyl Ester
6%